Navigation Links
New Analysis Estimates Numbers of Older U.S. Adults Who May Benefit From Statin Therapy
Date:1/14/2009

s, La.

"Based on our analysis, more than 44.7 million older Americans might have an indication for statin therapy when you consider those who already meet current guidelines for statin therapy and those who might be eligible based on the criteria proposed in JUPITER," said the study's lead author Erica S. Spatz, M.D., an internist and fellow in the Robert Wood Johnson Clinical Scholars Program at Yale University, New Haven, Conn. "That's nearly 80 percent of this segment of the population who could potentially be recommended a statin therapy if those criteria were adopted into guidelines."

The study is a numerical analysis rather than an endorsement of using statins to aggressively lower cholesterol and high sensitivity C-reactive protein (hsCRP) in people not currently considered candidates for that therapy, as was done in JUPITER. Additionally, the exclusion criteria for study participants in the JUPITER trial may make it difficult to generalize those findings.

"Certainly the JUPITER findings were intriguing and they will be evaluated as any future revisions are considered for treatment guidelines for reducing cardiovascular risk," said American Heart Association president Timothy Gardner, M.D. "This additional analysis of that data provides useful information about how many individuals would meet the JUPITER inclusion criteria. A more in-depth study of further implications, including cost-analysis, will be critical in future decision-making processes about preventive measures for the population as a whole. All of this will need to be carefully considered in the context of available resources and the most effective ways to make the most positive impact possible in reducing heart disease and stroke."

Spatz, who was not involved in the JUPITER trial, said her analysis does highlight an important challenge for healthcare providers and systems: Even under current treatment guideline
'/>"/>

SOURCE American Heart Association
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. NicOx Naproxcinod Shows Robust Blood Pressure Results in Phase 3 Pooled Analysis
2. Neurobiological Technologies Announces Viprinex(TM) Does Not Pass Interim Futility Analysis
3. Thoratec Says Interim Data Analysis Demonstrates Statistical Superiority for the HeartMate II(R) in Destination Therapy Trial
4. New Analysis Shows Troubling Trend in Triglyceride Levels May Be Linked to Rising Rates of Obesity
5. Dendreon Presents Integrated Analysis of Clinical Data from NEUVENGE Trials at Chemotherapy Foundation Symposium
6. Analysis of Long-Term Vicriviroc Data Provides Evidence of Sustained Viral Suppression, Increased CD4 Cell Counts and Tolerability in Treatment-Experienced HIV-Infected Patients
7. Interim Analysis of 12-Month Data from e-HEALING Registry Shows Good Safety and Efficacy in Real-World Use of OrbusNeichs Genous(TM) Bio-engineered R stent(TM)
8. Takedas Investigational PPI TAK-390MR Demonstrated Higher Healing Rates Compared to Lansoprazole as the Severity of Erosive Esophagitis Grade Increased, a New Integrated Analysis Showed
9. Fralex provides update on timing of interim analysis results
10. Analysis of Earlier European Stroke Trial Supports Treatment Regimen for Viprinex(TM) in Current International Phase 3 Clinical Trials
11. Epiphany Biosciences to Continue Phase 2 Shingles Study After Interim Analysis; Plans Follow-On Clinical Trial Studying Post-Herpetic Neuralgia (PHN)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... Ill. , July 28, 2015 Today,s ... on par with their levels of clinical excellence. Today ... Annual Meeting & Clinical Lab Expo, Sysmex is announcing ... a comprehensive and intuitive ecosystem that will help laboratories ... key areas, Sysmex aims to add even more value ...
(Date:7/28/2015)... 2015 Research and Markets ... "Global Post-traumatic Stress Disorder Therapeutics Market 2015-2019" ... therapeutics market to grow at a CAGR of 1.09% ... the present scenario and the growth prospects of the ... calculate the market size, the report considers revenue generated ...
(Date:7/28/2015)... , July 28, 2015   DigiPath Labs ... DIGP), is combining efforts with True North Laboratory of ... Romer Labs , a leading global supplier of diagnostic ... utilizing Romer Labs, rapid diagnostic test kits ... in cannabis. "This joint effort is expected ...
Breaking Medicine Technology:Sysmex Moves Beyond a Better Box 2Sysmex Moves Beyond a Better Box 3Sysmex Moves Beyond a Better Box 4Global Post-traumatic Stress Disorder Therapeutics Market 2015-2019 - Growing Number of Accidents and Violence Worldwide Drives the Market 2DigiPath Labs Partners with Romer Labs to Validate Food-Borne Pathogen and Mycotoxin Testing Solutions for Cannabis 2DigiPath Labs Partners with Romer Labs to Validate Food-Borne Pathogen and Mycotoxin Testing Solutions for Cannabis 3
... Get content from Novo Nordisk A/S at: ... Novo Nordisk announced on March 15 that the ... approved Victoza® for the treatment of type 2 ... the first once-daily human Glucagon-Like Peptide-1 (GLP-1) analogue ...
... patients in China will gain access to Varian,s state-of-the-art ... center is acquiring a GammaMed® brachytherapy afterloader from Varian ... high dose rate afterloader supplied to Chinese hospitals by ... Jilin University No. 1 Hospital in Jilin will ...
Cached Medicine Technology:Video from Novo Nordisk A/S available on thenewsmarket.com: Novo Nordisk Receives Approval for Victoza in China 2First Varian High Dose Rate Brachytherapy Afterloader Supplied to Leading China Cancer Hospital 2
(Date:7/28/2015)... , ... July 28, 2015 , ... Women fear developing ... reason is that cancer, heart attack, and stroke are treatable, but there is little ... can do is to take part in a clinical trial, reports the July 2015 ...
(Date:7/28/2015)... CA (PRWEB) , ... July 28, 2015 , ... ... of Acute Coronary Syndromes (ACS-Heart Attack, Sudden Death, or Angina), many of whom ... cardiology is the identification of individuals with active yet undetected sub-clinical disease, who ...
(Date:7/28/2015)... ... July 28, 2015 , ... ... for identifying Top Doctors, has based its selection process on the foundation of ... in their medical specialties, in any area of medicine and in any part ...
(Date:7/28/2015)... ... 2015 , ... One of the most common running related ... plantar fasciitis . Zensah, the Miami-based compression brand, offers a product that can ... the Zensah Ankle Support’s primary benefits include helping support the ankle, reduce swelling, ...
(Date:7/28/2015)... ... July 28, 2015 , ... Nurses across all settings ... up to 57 million Americans may need mental health services (SAMHSA, 2013) and the ... Psychiatric-mental health RNs are one of the largest workforces who provide care to ...
Breaking Medicine News(10 mins):Health News:Fight Alzheimer's By Taking Part in a Clinical Trial, From the July 2015 Harvard Women's Health Watch 2Health News:Fight Alzheimer's By Taking Part in a Clinical Trial, From the July 2015 Harvard Women's Health Watch 3Health News:Utility of a novel coronary artery disease biomarker algorithm in modifying physician adherence to guideline therapy presented at 20th World Congress on Heart Disease 2Health News:Fort Myers Plastic Surgeon Recognized as One of the America’s “Top Doctors®” by Prestigious Castle Connolly Medical Ltd. for 5 Years in a Row 2Health News:Fort Myers Plastic Surgeon Recognized as One of the America’s “Top Doctors®” by Prestigious Castle Connolly Medical Ltd. for 5 Years in a Row 3Health News:Zensah Releases Compression Sleeve To Relieve Ankle Pain and Plantar Fasciitis 2Health News:American Psychiatric Nurses Association Transitions in Practice Certificate Program to Improve Mental Health Care Through Continuing Nursing Education 2Health News:American Psychiatric Nurses Association Transitions in Practice Certificate Program to Improve Mental Health Care Through Continuing Nursing Education 3Health News:American Psychiatric Nurses Association Transitions in Practice Certificate Program to Improve Mental Health Care Through Continuing Nursing Education 4
... A novel gene called rumi regulates Notch signaling by ... Notch protein that extends outside a cell, said researchers ... Brook University in New York in a report that ... governed by the Notch protein determines cell fate determination ...
... works for allergic asthma, rhinitis, conjunctivitis or insect ... If you have allergic asthma, rhinitis, conjunctivitis or ... candidate for allergy shots, also known as immunotherapy. ... of Allergy, Asthma & Immunology. , "Immunotherapy is ...
... MYL ),today announced that it intends to appeal ... for the District of Columbia against Mylan and its ... of the,pending Lorazepam and Clorazepate antitrust cases. The first ... disclosed, in June 2005, a jury in the district ...
... Society of Plastic Surgeons (ASPS) today addressed concerns,regarding ... events following,a recent petition from a consumer group., ... U.S. Food and Drug,Administration (FDA) implement labeling changes ... one million people have been treated with BOTOX ...
... Unland, President of the,Chicago-based Health Capital Group, urged hospitals, ... their existing debt instruments, their,obligations and their capital and ... Problems with some major banks and bond insurers have ... do so for some time to come,resulting in both ...
... no medical benefit; heart expert calls it ,second-line, ... The controversy surrounding the highly promoted cholesterol-lowering drug ... they would review the medication,s effectiveness, but only ... debate began earlier this month when preliminary results ...
Cached Medicine News:Health News:Notch-ing glucose into place 2Health News:Allergy Shots Are Effective Treatment for Symptoms 2Health News:Mylan Provides Update Relating to Ongoing Lorazepam and Clorazepate Litigation 2Health News:ASPS Addresses Concerns Regarding BOTOX Treatments 2Health News:Health Capital Group Warns of Fallout to Hospitals From the Subprime Mortgage Crisis and Urges Hospitals to Immediately Reassess Existing Debt Structures and Capital Financing Plans 2Health News:FDA Will Wait for Trial Results on Vytorin 2Health News:FDA Will Wait for Trial Results on Vytorin 3
... advanced 16 to 64 channel sleep diagnostic ... 16 to 64 channel sleep diagnostic collection ... sleep event recording or post recording. The ... recorded during sleep events including current number ...
Aurora is a powerful Windows-based digital PSG instrument providing complete data acquisition, recording and review capabilities in one flexible package. The Aurora offers the most feature-packed PSG...
... gold-ball electrodes in a double-horn assembly ... electrode is in a ball and ... Supporting bone clamp design simplifies three ... braided, Teflon-coated wires terminate in a ...
... Medelec Synergy N-EP provides total testing ... smaller instrument is driven by space ... testing equipment on the move ... 2, 5, or 10-channel Medelec Synergy ...
Medicine Products: